En esta página
01INBX precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
INBX Inhibrx Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026
$96,99
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$28,16mínimo 52 semanas
$155,29máximo 52 semanas
Capitalización Bursátil (MRQ)
$1.43B
P/E
-10.8
BPA
$-9.04
Ingresos
$1M
tus insignias
Rango 52S
$28–$155
Calificación del Analista
BUY
Precio Objetivo
$267
P/E
-10.8
ROE
-365.9%
Margen de Beneficio Neto
-10773.5%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
INBX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$96.99
Capitalización Bursátil (MRQ)
$1.43B
P/E
-10.8
BPA
$-9.04
Ingresos
$1M
ROE
-365.9%
Deuda/Capital (MRQ)
-3.3
Rango 52S
$28–$155
INBX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$1M2023-12-31 → 2025-12-31
BPA$-9.042023-12-31 → 2025-12-31
Flujo de caja libre$-130M2024-12-31 → 2025-12-31
Margen neto-10773.5%2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | INBX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -10.8 | · | · | · | |
| P/S | 1089.9 | · | 9.6 | Sobrevalorado | |
| P/C (MRQ) | -26.9 | · | · | · | |
| EV / EBITDA | -10.5 | · | · | · | |
| Precio / FCF (TTM) | -10.8 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -10.8 | · | · | · | |
| EV / Revenue (EV / Ingresos) | 1071.7 | · | · | · | |
| EV / FCF | -10.7 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 177.3 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | INBX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -10386.5% | · | -104.0% | Débil | |
| EBITDA Margin (Margen EBITDA) | -10195.5% | · | -103.7% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -10773.3% | · | -124.8% | Débil | |
| Net Profit Margin (Margen de Beneficio Neto) | -10773.5% | · | -137.4% | Débil | |
| ROA | -85.6% | · | -37.9% | Débil | |
| ROE | -365.9% | · | -42.7% | Débil | |
| ROIC | -124.4% | · | -25.6% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | INBX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | -3.3 | · | 0.1 | Baja deuda | |
| Ratio corriente (MRQ) | 5.1 | · | 9.3 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 3.7 | · | 5.1 | En línea | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | -3.3 | · | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | INBX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 550.0% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | INBX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0 | · | 0.2 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$11.9K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-1.6%
Próximo informe
Nov 12, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 13, 2026 | $-2.34 | $-2.44 | 4.0% |
| 31 de marzo de 2026 | May 14, 2026 | $-2.15 | $-1.82 | -18.0% |
| 31 de diciembre de 2025 | $-2.11 | $-2.12 | 0.40% | |
| 30 de septiembre de 2025 | $-2.28 | $-1.75 | -30.1% | |
| 30 de junio de 2025 | $-1.85 | $-2.82 | 34.3% | |
| 31 de marzo de 2025 | $-2.80 | $-2.90 | 3.3% | |
| 31 de diciembre de 2024 | $-3.09 | $-2.94 | -5.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1M | $200.0K | $2M | |
| R&D Expense | $113M | $204M | $192M | |
| SG&A Expense | $23M | $128M | $29M | |
| Operating Expenses | $136M | $332M | $221M | |
| Operating Income | $-135M | $-331M | $-219M | |
| Other Non-op | $-381.0K | $75.0K | $-580.0K | |
| Pretax Income | $-140M | $1.69B | $-240M | |
| Income Tax | $2.0K | $2.0K | $3.0K | |
| Net Income | $-140M | $1.69B | $-241M | |
| EPS (Basic) | $-9.04 | $114.01 | $-20.48 | |
| EPS (Diluted) | $-9.04 | $112.62 | $-20.48 | |
| Shares (Basic) | 15,487,000 | 14,802,000 | 11,783,000 | |
| Shares (Diluted) | 15,487,000 | 14,984,000 | 11,783,000 | |
| EBITDA | $-133M | $-329M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $124M | $153M | $278M | |
| Prepaid Expense | $8M | $7M | $17M | |
| Other Current Assets | $238.0K | $382.0K | $366.0K | |
| Current Assets | $133M | $160M | $295M | |
| PP&E (Net) | $4M | $6M | $6M | |
| PP&E (Gross) | $15M | $15M | $13M | |
| Accum. Depreciation | $11M | $9M | $7M | |
| Other Non-current Assets | $4M | $7M | $3M | |
| Total Assets | $146M | $181M | $308M | |
| Accounts Payable | $6M | $9M | $11M | |
| Accrued Liabilities | $26M | $30M | $43M | |
| Current Liabilities | $34M | $41M | $56M | |
| Capital Leases | $4M | $6M | $1M | |
| Total Liabilities | $138M | $47M | $264M | |
| Total Debt | $101M | $0 | · | |
| Common Stock | $1.0K | $1.0K | $5.0K | |
| Paid-in Capital | $254M | $240M | $657M | |
| Retained Earnings | $-246M | $-106M | $-614M | |
| Stockholders' Equity | $8M | $134M | $44M | |
| Liabilities + Equity | $146M | $181M | $308M | |
| Shares Outstanding | 14,577,609 | 14,476,000 | 47,369,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $1M | |
| Stock-based Comp | $11M | $59M | $25M | |
| Other Non-cash | $-3M | $-1.94B | · | |
| Operating Cash Flow | $-130M | $-194M | $-193M | |
| CapEx | $31.0K | $3M | $5M | |
| Investing Cash Flow | $-28.0K | $-3M | $-5M | |
| Financing Cash Flow | $101M | $72M | $202M | |
| Net Change in Cash | $-28M | $-125M | $4M | |
| Taxes Paid | $2.0K | $2.0K | $3.0K | |
| Free Cash Flow | $-130M | $-197M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -10386.5% | -165724.0% | · | |
| Net Margin | -10773.5% | 843786.0% | · | |
| Pretax Margin | -10773.3% | 843787.0% | · | |
| EBITDA Margin | -10195.5% | -164581.5% | · | |
| ROA | -85.6% | 690.7% | · | |
| ROE | -365.9% | 1081.6% | · | |
| ROIC | -124.4% | -248.1% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.9 | 3.9 | · | |
| Quick Ratio | 3.7 | 3.7 | · | |
| Debt / Equity | 12.6 | 0.0 | · | |
| LT Debt / Equity | 12.6 | 0.0 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.55 | $9.23 | · | |
| Revenue / Share | $0.08 | $0.01 | · | |
| Cash Flow / Share | $-8.38 | $-12.97 | · | |
| Cash / Share | $8.52 | $10.54 | · | |
| EPS (TTM) | $-9.04 | $112.62 | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 550.0% | -88.9% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $1M | $200.0K | · | |
| Net Income TTM | $-140M | $1.69B | · | |
| Market Cap | $1.15B | $223M | · | |
| Enterprise Value | $1.13B | $70M | · | |
| P/E | -8.7 | 0.1 | · | |
| P/S | 885.9 | 1114.6 | · | |
| P/B | 144.1 | 1.7 | · | |
| P / Tangible Book | 144.1 | 1.7 | · | |
| P / Cash Flow | -8.9 | -1.1 | · | |
| P / FCF | -8.9 | -1.1 | · | |
| EV / EBITDA | -8.5 | -0.2 | · | |
| EV / FCF | -8.7 | -0.4 | · | |
| EV / Revenue | 867.7 | 351.7 | · | |
| Earnings Yield | -11.4% | 731.3% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | $0 | $0 | $1M | $0 | $100.0K | $0 | $100.0K | $0 | $2M | $119.0K | $30.0K | |
| R&D Expense | $24M | $25M | $25M | $29M | $22M | $37M | $33M | $39M | $68M | $64M | $82M | $38M | $34M | |
| SG&A Expense | $8M | $6M | $6M | $5M | $6M | $6M | $17M | $8M | $93M | $10M | $8M | $8M | $7M | |
| Operating Expenses | $32M | $31M | $31M | $34M | $29M | $43M | $50M | $47M | $161M | $74M | $90M | $46M | $41M | |
| Operating Income | $-32M | $-31M | $-31M | $-34M | $-27M | $-43M | $-50M | $-47M | $-161M | $-74M | $-88M | $-46M | $-41M | |
| Other Non-op | $-68.0K | $-12.0K | $-39.0K | $-46.0K | $-246.0K | $-50.0K | $60.0K | $41.0K | $33.0K | $-59.0K | $-158.0K | $-135.0K | $-217.0K | |
| Pretax Income | $-37M | $-33M | $-33M | $-35M | $-29M | $-43M | $-48M | $-44M | $1.86B | $-79M | $-92M | $-52M | $-47M | |
| Income Tax | $3.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | $-4.0K | $2.0K | $5.0K | |
| Net Income | $-37M | $-33M | $-33M | $-35M | $-29M | $-43M | $-48M | $-44M | $1.86B | $-79M | $-94M | $-52M | $-47M | |
| EPS (Basic) | $-2.34 | $-2.15 | $-2.11 | $-2.28 | $-1.85 | $-2.80 | $-4.48 | $-2.84 | $127.10 | $-5.77 | $-7.29 | $-4.39 | $-4.31 | |
| EPS (Diluted) | $-2.34 | $-2.15 | $-2.11 | $-2.28 | $-1.85 | $-2.80 | $-4.25 | $-2.84 | $125.48 | $-5.77 | $-7.29 | $-4.39 | $-4.31 | |
| Shares (Basic) | 15,669,000 | 15,585,000 | · | 15,478,000 | 15,468,000 | 15,468,000 | · | 15,468,000 | 14,619,000 | 13,639,000 | · | 11,788,000 | 10,911,000 | |
| Shares (Diluted) | 15,669,000 | 15,585,000 | · | 15,478,000 | 15,468,000 | 15,468,000 | · | 15,468,000 | 14,807,000 | 13,639,000 | · | 11,788,000 | 10,911,000 | |
| EBITDA | $-32M | $-30M | · | $-33M | $-27M | $-42M | · | $-46M | $-160M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $133M | $162M | $124M | $153M | $187M | $217M | $153M | $196M | $227M | · | $278M | · | · | |
| Prepaid Expense | $9M | $9M | $8M | $7M | $6M | $7M | $7M | $10M | $14M | · | $17M | · | · | |
| Other Current Assets | $574.0K | $262.0K | $238.0K | $410.0K | $283.0K | $269.0K | $382.0K | $748.0K | $966.0K | · | $366.0K | · | · | |
| Current Assets | $142M | $171M | $133M | $161M | $194M | $223M | $160M | $207M | $242M | · | $295M | · | · | |
| PP&E (Net) | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $8M | · | $6M | · | · | |
| PP&E (Gross) | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $13M | · | · | |
| Accum. Depreciation | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $8M | $7M | · | $7M | · | · | |
| Other Non-current Assets | $5M | $4M | $4M | $6M | $7M | $7M | $7M | $7M | $7M | · | $3M | · | · | |
| Total Assets | $154M | $184M | $146M | $177M | $212M | $243M | $181M | $223M | $258M | · | $308M | · | · | |
| Accounts Payable | $10M | $9M | $6M | $7M | $8M | $9M | $9M | $12M | $13M | · | $11M | · | · | |
| Accrued Liabilities | $16M | $15M | $26M | $27M | $28M | $33M | $30M | $30M | $24M | · | $43M | · | · | |
| Current Liabilities | $28M | $27M | $34M | $36M | $39M | $44M | $41M | $44M | $39M | · | $56M | · | · | |
| Capital Leases | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $0 | $0 | · | $1M | · | · | |
| Total Liabilities | $207M | $205M | $138M | $141M | $144M | $148M | $47M | $44M | $39M | · | $264M | · | · | |
| Total Debt | $176M | $175M | · | $100M | $99M | $99M | · | $0 | $0 | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | $5.0K | · | · | |
| Paid-in Capital | $263M | $259M | $254M | $250M | $247M | $244M | $240M | $237M | $234M | · | $657M | · | · | |
| Retained Earnings | $-316M | $-280M | $-246M | $-213M | $-178M | $-149M | $-106M | $-58M | $-14M | · | $-614M | · | · | |
| Stockholders' Equity | $-53M | $-21M | $8M | $37M | $69M | $94M | $134M | $178M | $219M | · | $44M | · | · | |
| Liabilities + Equity | $154M | $184M | $146M | $177M | $212M | $243M | $181M | $223M | $258M | · | $308M | · | · | |
| Shares Outstanding | 14,708,910 | 14,607,286 | 14,577,609 | 14,498,093 | 14,475,904 | 14,475,904 | 14,475,904 | 14,475,904 | 14,475,904 | · | 47,369,511 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $523.0K | $537.0K | $564.0K | $582.0K | $662.0K | $675.0K | $690.0K | $760.0K | $475.0K | $360.0K | $298.0K | $304.0K | $295.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $46M | $6M | $6M | $7M | · | |
| Other Non-cash | · | $-8M | · | · | · | $4M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-30M | $-38M | $-30M | $-34M | $-30M | $-36M | $-44M | $-30M | $-57M | $-63M | $-57M | $-54M | · | |
| CapEx | $0 | $0 | $0 | $10.0K | $0 | $21.0K | $16.0K | $247.0K | $1M | $1M | $3M | $811.0K | · | |
| Investing Cash Flow | $0 | $0 | $0 | $-7.0K | $0 | $-21.0K | $-16.0K | $-247.0K | $-1M | $-1M | $-3M | $-811.0K | · | |
| Financing Cash Flow | $2M | $75M | $1M | $352.0K | $0 | $100M | $0 | $0 | $33M | $39M | $860.0K | $200M | · | |
| Net Change in Cash | $-28M | $37M | $-29M | $-33M | $-30M | $64M | $-44M | $-31M | $-26M | $-25M | $-59M | $145M | · | |
| Taxes Paid | $3.0K | $0 | $0 | $0 | $2.0K | $0 | $0 | $0 | $2.0K | $0 | · | · | · | |
| Free Cash Flow | · | $-38M | · | · | · | $-36M | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2106.8% | · | · | · | -160898.0% | · | · | · | · | |
| Net Margin | · | · | · | · | -2204.2% | · | · | · | 1858011.0% | · | · | · | · | |
| Pretax Margin | · | · | · | · | -2204.0% | · | · | · | 1858013.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -2055.9% | · | · | · | -160423.0% | · | · | · | · | |
| ROA | -20.0% | -15.7% | · | -17.6% | -12.2% | -35.7% | · | -39.4% | 1438.0% | · | · | · | · | |
| ROE | -470.4% | -91.1% | · | -32.8% | -19.9% | -91.7% | · | -49.2% | 1694.0% | · | · | · | · | |
| ROIC | -26.1% | -20.1% | · | -24.7% | -16.3% | -22.2% | · | -26.2% | -73.4% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 6.5 | · | 4.5 | 5.0 | 5.1 | · | 4.7 | 6.2 | · | · | · | · | |
| Quick Ratio | 4.8 | 6.1 | · | 4.3 | 4.8 | 5.0 | · | 4.5 | 5.8 | · | · | · | · | |
| Debt / Equity | -3.3 | -8.3 | · | 2.7 | 1.4 | 1.0 | · | 0.0 | 0.0 | · | · | · | · | |
| LT Debt / Equity | -3.3 | -8.3 | · | 2.7 | 1.4 | 1.0 | · | 0.0 | 0.0 | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-3.60 | $-1.44 | · | $2.54 | $4.74 | $6.52 | · | $12.33 | $15.15 | · | · | · | · | |
| Revenue / Share | $0.00 | · | · | $0.00 | $0.08 | $0.00 | · | $0.00 | $0.01 | · | · | · | · | |
| Cash Flow / Share | · | $-2.44 | · | · | · | $-2.32 | · | · | · | · | · | · | · | |
| Cash / Share | $9.07 | $11.07 | · | $10.56 | $12.89 | $14.96 | · | $13.56 | $15.67 | · | · | · | · | |
| EPS (TTM) | $-8.88 | $-8.39 | · | $-11.18 | $-11.74 | $115.59 | · | $109.58 | $108.03 | $-21.76 | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1M | · | $1M | $1M | $200.0K | · | $2M | $2M | $2M | · | · | · | |
| Net Income TTM | $-138M | $-130M | · | $-155M | $-164M | $1.72B | · | $1.64B | $1.63B | $-271M | · | · | · | |
| Market Cap | $1.39B | $982M | · | $488M | $207M | $203M | · | $227M | $205M | · | · | · | · | |
| Enterprise Value | $1.44B | $995M | · | $435M | $119M | $85M | · | $30M | $-22M | · | · | · | · | |
| P/E | -10.7 | -8.0 | · | -3.0 | -1.2 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | |
| P/S | · | 755.4 | · | 348.8 | 147.6 | 1012.6 | · | 130.7 | 110.7 | · | · | · | · | |
| P/B | -26.3 | -46.7 | · | 13.3 | 3.0 | 2.1 | · | 1.3 | 0.9 | · | · | · | · | |
| P / Tangible Book | · | · | · | 13.3 | 3.0 | 2.1 | · | 1.3 | 0.9 | · | · | · | · | |
| P / Cash Flow | · | -25.8 | · | · | · | -5.6 | · | · | · | · | · | · | · | |
| EV / Revenue | · | 765.7 | · | 310.8 | 85.2 | 423.3 | · | 17.5 | -11.7 | · | · | · | · | |
| Earnings Yield | -9.4% | -12.5% | · | -33.2% | -82.3% | 826.2% | · | 699.7% | 762.4% | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Ingresos | $1M | $200.0K | $2M |
| Margen Operativo % | -10386.5% | -165724.0% | · |
| Beneficio neto | $-140M | $1.69B | $-241M |
| EPS Diluido | $-9.04 | $112.62 | $-20.48 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Deuda / Patrimonio | 12.6 | 0.0 | · |
| Ratio corriente | 3.9 | 3.9 | · |
| Ratio Rápido | 3.7 | 3.7 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Flujo de caja libre | $-130M | $-197M | · |
Propietarios institucionales (13F) 178 declarantes · $1.4B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
178
Valor en tenencia
$1.4B
Nuevas posiciones
49
Posiciones cerradas
19
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 49 (+21 vs trimestre anterior) | 19 (-6 vs trimestre anterior) | 61 (+7 vs trimestre anterior) | 41 (+1 vs trimestre anterior) | +1.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MORGAN STANLEY | $123 937 898 | 1 308 051 | 8,63% | Acciones |
| PERCEPTIVE ADVISORS LLC | $122 963 044 | 1 297 763 | 8,56% | Acciones |
| Sanofi | $109 713 489 | 1 157 926 | 7,64% | Acciones |
| VIKING GLOBAL INVESTORS LP | $106 492 273 | 1 123 929 | 7,41% | Acciones |
| HighTower Advisors, LLC | $82 484 676 | 870 551 | 5,74% | Acciones |
| BANK OF AMERICA CORP /DE/ | $79 698 110 | 841 141 | 5,55% | Acciones |
| BlackRock, Inc. | $78 260 825 | 825 972 | 5,45% | Acciones |
| Schonfeld Strategic Advisors LLC | $66 096 272 | 697 586 | 4,60% | Acciones |
| STATE STREET CORP | $60 683 396 | 640 458 | 4,22% | Acciones |
| VANGUARD GROUP INC | $49 223 636 | 623 084 | 3,43% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $46 662 196 | 492 477 | 3,25% | Acciones |
| Woodline Partners LP | $37 984 517 | 400 892 | 2,64% | Acciones |
| Capital Research Global Investors | $34 398 988 | 363 050 | 2,39% | Acciones |
| GOLDMAN SACHS GROUP INC | $32 042 176 | 338 176 | 2,23% | Acciones |
| PFM Health Sciences, LP | $29 219 479 | 308 385 | 2,03% | Acciones |
| Sofinnova Investments, Inc. | $28 719 009 | 303 103 | 2,00% | Acciones |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $25 743 575 | 271 700 | 1,79% | Acciones |
| Parkman Healthcare Partners LLC | $24 346 013 | 256 950 | 1,69% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $24 278 247 | 256 175 | 1,69% | Acciones |
| First Turn Management, LLC | $15 613 189 | 164 783 | 1,09% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $13 947 200 | 147 200 | 0,97% | Acciones |
| CDC Financial, Inc. | $13 277 318 | 140 130 | 0,92% | Acciones |
| FIRST TRUST ADVISORS LP | $12 168 174 | 128 424 | 0,85% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11 612 276 | 122 557 | 0,81% | Acciones |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $11 294 200 | 119 200 | 0,79% | Acciones |
| NORTHERN TRUST CORP | $9 565 676 | 100 957 | 0,67% | Acciones |
| NORGES BANK | $8 555 925 | 90 300 | 0,60% | Acciones |
| CITIGROUP INC | $7 174 565 | 75 721 | 0,50% | Acciones |
| Jefferies Financial Group Inc. | $6 956 166 | 73 416 | 0,48% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 840 950 | 72 200 | 0,48% | Opción de compra |
| VANGUARD FIDUCIARY TRUST CO | $6 624 920 | 69 920 | 0,46% | Acciones |
| GOLDMAN SACHS GROUP INC | $6 300 875 | 66 500 | 0,44% | Opción de compra |
| RENAISSANCE TECHNOLOGIES LLC | $5 893 545 | 62 201 | 0,41% | Acciones |
| EVENTIDE ASSET MANAGEMENT, LLC | $5 831 389 | 61 545 | 0,41% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $5 669 935 | 59 841 | 0,39% | Acciones |
| Voleon Capital Management LP | $5 529 421 | 58 358 | 0,38% | Acciones |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4 620 484 | 48 765 | 0,32% | Acciones |
| Western Standard LLC | $4 453 250 | 47 000 | 0,31% | Acciones |
| NOMURA HOLDINGS INC | $3 837 375 | 40 500 | 0,27% | Opción de compra |
| Caption Management, LLC | $3 827 900 | 40 400 | 0,27% | Opción de compra |
| CITADEL ADVISORS LLC | $3 534 175 | 37 300 | 0,25% | Opción de compra |
| VICTORY CAPITAL MANAGEMENT INC | $3 452 974 | 36 443 | 0,24% | Acciones |
| ArrowMark Colorado Holdings LLC | $3 332 926 | 35 176 | 0,23% | Acciones |
| UBS Group AG | $3 318 050 | 35 019 | 0,23% | Acciones |
| HUSSMAN STRATEGIC ADVISORS, INC. | $2 984 625 | 31 500 | 0,21% | Acciones |
| Empyrean Capital Partners, LP | $2 842 500 | 30 000 | 0,20% | Acciones |
| CDC Financial, Inc. | $2 842 500 | 30 000 | 0,20% | Opción de compra |
| Atom Investors LP | $2 804 032 | 29 594 | 0,20% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 717 241 | 28 678 | 0,19% | Acciones |
| Corient Private Wealth LP | $2 714 873 | 28 653 | 0,19% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| The Jon F. Kayyem and Paige Gates-Kayyem Family Trust, Jon Faiz Kayyem ×2 presentaciones | 26 de febrero de 2025 | 7,90% | Enmienda | · | SEC |
| Mark Lappe ×2 presentaciones | 26 de febrero de 2025 | 6,40% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 9 insiders · 4 directivos · 5 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Mark Lappe | Chief Executive Officer | 28 de septiembre de 2026 P | 740 548 | 10 | 0 | $3 644 153 |
| Kelly Deck | Chief Financial Officer | 1 de abril de 2025 A | · | 0 | 0 | $0 |
| David Matly | President | 24 de abril de 2026 A | · | 0 | 0 | $0 |
| Brendan P. Eckelman | Chief Scientific Officer | 30 de mayo de 2024 A | 40 000 | 0 | 0 | $0 |
| Jon Faiz Kayyem | Consejero | 23 de septiembre de 2026 P | 434 360 | 3 | 0 | $1 567 600 |
| Kristiina Vuori MD | Consejero | 3 de junio de 2026 A | 20 443 | 0 | 0 | $0 |
| Douglas Forsyth | Consejero | 3 de junio de 2026 A | 227 064 | 1 | 0 | $286 625 |
| Kimberly Manhard | Consejero | 3 de junio de 2026 A | 7 500 | 0 | 5 | $-279 015 |
| Inhibrx, Inc. | Propietario del 10% | 29 de mayo de 2024 J | 1 157 926 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 28 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,60% | 3 371 NS | 31 de julio de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,47% | 74 091 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,23% | 13 627 NS | 31 de julio de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,22% | 36 827 NS | 31 de julio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,13% | 27 554 SH | 19 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 1 036 SH | 1 de octubre de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 6 714 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 82 742 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,06% | 186 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,06% | 73 332 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 8 415 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 10 484 SH | 1 de octubre de 2026 | Diario |
| IWM · iShares Trust | 0,04% | 244 961 SH | 11 de septiembre de 2026 | Diario |
| ISCG · iShares Trust | 0,03% | 2 913 SH | 9 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 54 768 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,03% | 4 552 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 110 905 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1 460 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 20 879 SH | 19 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 3 429 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 467 SH | 10 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 13 967 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 1 963 SH | 9 de septiembre de 2026 | Diario |
| RYLD · Global X Funds | 0,00% | 15 798 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 369 641 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 781 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 16 842 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 398 SH | 11 de septiembre de 2026 | Diario |
INBX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 10 analistas
COMPRA
Objetivo mediano
$245.00
+152,6%
3 30,0%
Compra fuerte
5 50,0%
Compra
2 20,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-09-28Objetivo medio $266.67 +174,9%
← Por Debajo de Todos los Objetivos
Precio Actual $96.99
Mín$230.00
Media$266.67
Máx$325.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| COAG | · | · | · | · | · | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
| KLRA | · | · | · | · | · | · |
| ORIC | $806M | -5.6 | · | · | -36.5% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 13, 2026